Titre : Glycosylation

Glycosylation : Questions médicales fréquentes

Termes MeSH sélectionnés :

Regression Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Glycosylation : Questions médicales les plus fréquentes", "headline": "Glycosylation : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Glycosylation : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-04", "dateModified": "2025-04-29", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Glycosylation" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Métabolisme glucidique", "url": "https://questionsmedicales.fr/mesh/D050260", "about": { "@type": "MedicalCondition", "name": "Métabolisme glucidique", "code": { "@type": "MedicalCode", "code": "D050260", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G03.191" } } }, "about": { "@type": "MedicalCondition", "name": "Glycosylation", "alternateName": "Glycosylation", "code": { "@type": "MedicalCode", "code": "D006031", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Christian Marcus Pedersen", "url": "https://questionsmedicales.fr/author/Christian%20Marcus%20Pedersen", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, University of Copenhagen, Universitetsparken 5, 2100 Copenhagen Ø, Denmark." } }, { "@type": "Person", "name": "Yanjing Li", "url": "https://questionsmedicales.fr/author/Yanjing%20Li", "affiliation": { "@type": "Organization", "name": "Department of Emergency, State Key Laboratory of Biotherapy, West China Hospital, and School of Chemical Engineering, Sichuan University, No. 17 Renmin Nan Road, Chengdu, 610041, China." } }, { "@type": "Person", "name": "Dawen Niu", "url": "https://questionsmedicales.fr/author/Dawen%20Niu", "affiliation": { "@type": "Organization", "name": "Department of Emergency, State Key Laboratory of Biotherapy, West China Hospital, and School of Chemical Engineering, Sichuan University, No. 17 Renmin Nan Road, Chengdu, 610041, China." } }, { "@type": "Person", "name": "Liang Yang", "url": "https://questionsmedicales.fr/author/Liang%20Yang", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, University of Copenhagen, Universitetsparken 5, 2100 Copenhagen Ø, Denmark." } }, { "@type": "Person", "name": "Boon Chong Lee", "url": "https://questionsmedicales.fr/author/Boon%20Chong%20Lee", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, National University of Singapore, 4 Science Drive 2, Singapore, 117544, Republic of Singapore." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Estimating reference intervals from an IPD meta-analysis using quantile regression.", "datePublished": "2024-10-26", "url": "https://questionsmedicales.fr/article/39462323", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12874-024-02378-0" } }, { "@type": "ScholarlyArticle", "name": "Hospitalization costs of road traffic injuries in Hunan, China: A quantile regression analysis.", "datePublished": "2023-10-30", "url": "https://questionsmedicales.fr/article/37907040", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.aap.2023.107368" } }, { "@type": "ScholarlyArticle", "name": "Incidence and Prognostic Implications of Cardiac-Implantable Device-Associated Tricuspid Regurgitation: A Meta-Analysis and Meta-Regression Analysis.", "datePublished": "2023-10-17", "url": "https://questionsmedicales.fr/article/37863117", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.amjcard.2023.09.064" } }, { "@type": "ScholarlyArticle", "name": "Relationship between obsessive compulsive symptomatology and severity of psychotic symptoms in schizophrenia: Meta-analysis and meta-regression analysis.", "datePublished": "2022-12-20", "url": "https://questionsmedicales.fr/article/36549240", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.schres.2022.12.013" } }, { "@type": "ScholarlyArticle", "name": "Endoscopic third ventriculostomy for shunt malfunction in the pediatric population: a systematic review, meta-analysis, and meta-regression analysis.", "datePublished": "2023-02-10", "url": "https://questionsmedicales.fr/article/36787128", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3171/2023.1.PEDS22427" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Métabolisme", "item": "https://questionsmedicales.fr/mesh/D008660" }, { "@type": "ListItem", "position": 3, "name": "Métabolisme glucidique", "item": "https://questionsmedicales.fr/mesh/D050260" }, { "@type": "ListItem", "position": 4, "name": "Glycosylation", "item": "https://questionsmedicales.fr/mesh/D006031" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Glycosylation - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Glycosylation", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Glycosylation", "description": "Comment diagnostiquer une anomalie de glycosylation ?\nQuels tests sanguins sont utilisés pour la glycosylation ?\nLes biopsies sont-elles utiles pour la glycosylation ?\nQuels symptômes indiquent une anomalie de glycosylation ?\nPeut-on utiliser l'imagerie pour diagnostiquer la glycosylation ?", "url": "https://questionsmedicales.fr/mesh/D006031?mesh_terms=Regression+Analysis&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Glycosylation", "description": "Quels sont les symptômes d'une glycosylation anormale ?\nLa fatigue est-elle un symptôme de glycosylation ?\nLes troubles digestifs sont-ils liés à la glycosylation ?\nY a-t-il des symptômes cutanés associés ?\nLes problèmes de croissance sont-ils fréquents ?", "url": "https://questionsmedicales.fr/mesh/D006031?mesh_terms=Regression+Analysis&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Glycosylation", "description": "Peut-on prévenir les anomalies de glycosylation ?\nLe dépistage génétique est-il recommandé ?\nLes vaccinations aident-elles à prévenir les complications ?\nY a-t-il des conseils diététiques préventifs ?\nLes consultations médicales régulières sont-elles importantes ?", "url": "https://questionsmedicales.fr/mesh/D006031?mesh_terms=Regression+Analysis&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Glycosylation", "description": "Quels traitements existent pour les anomalies de glycosylation ?\nLes enzymes de remplacement sont-elles efficaces ?\nLa diététique joue-t-elle un rôle dans le traitement ?\nLes médicaments immunosuppresseurs sont-ils utilisés ?\nY a-t-il des traitements expérimentaux disponibles ?", "url": "https://questionsmedicales.fr/mesh/D006031?mesh_terms=Regression+Analysis&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Glycosylation", "description": "Quelles sont les complications possibles de la glycosylation ?\nLes infections sont-elles fréquentes chez ces patients ?\nY a-t-il des risques de cancer associés ?\nLes troubles cardiovasculaires sont-ils liés ?\nLes complications psychologiques sont-elles possibles ?", "url": "https://questionsmedicales.fr/mesh/D006031?mesh_terms=Regression+Analysis&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Glycosylation", "description": "Quels sont les facteurs de risque pour les anomalies de glycosylation ?\nL'âge joue-t-il un rôle dans la glycosylation ?\nLes facteurs environnementaux influencent-ils la glycosylation ?\nLes maladies métaboliques augmentent-elles le risque ?\nLe sexe a-t-il un impact sur la glycosylation ?", "url": "https://questionsmedicales.fr/mesh/D006031?mesh_terms=Regression+Analysis&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie de glycosylation ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses de glycoprotéines sont utilisés." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés pour la glycosylation ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de glycoprotéines et les profils glycosylés sont courants." } }, { "@type": "Question", "name": "Les biopsies sont-elles utiles pour la glycosylation ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les biopsies tissulaires peuvent révéler des anomalies de glycosylation." } }, { "@type": "Question", "name": "Quels symptômes indiquent une anomalie de glycosylation ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des retards de développement, des problèmes immunitaires et des anomalies neurologiques." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie pour diagnostiquer la glycosylation ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie n'est pas spécifique, mais peut aider à évaluer des complications." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une glycosylation anormale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles neurologiques, des infections fréquentes et des anomalies physiques." } }, { "@type": "Question", "name": "La fatigue est-elle un symptôme de glycosylation ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fatigue peut être un symptôme associé à des troubles de glycosylation." } }, { "@type": "Question", "name": "Les troubles digestifs sont-ils liés à la glycosylation ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles digestifs peuvent être liés à des anomalies de glycosylation." } }, { "@type": "Question", "name": "Y a-t-il des symptômes cutanés associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées et des anomalies de la peau peuvent survenir." } }, { "@type": "Question", "name": "Les problèmes de croissance sont-ils fréquents ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des retards de croissance peuvent être observés chez les patients affectés." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies de glycosylation ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un diagnostic précoce peut aider à gérer les symptômes." } }, { "@type": "Question", "name": "Le dépistage génétique est-il recommandé ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage génétique peut être utile pour les familles à risque." } }, { "@type": "Question", "name": "Les vaccinations aident-elles à prévenir les complications ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations peuvent réduire le risque d'infections chez ces patients." } }, { "@type": "Question", "name": "Y a-t-il des conseils diététiques préventifs ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut soutenir la santé globale et le système immunitaire." } }, { "@type": "Question", "name": "Les consultations médicales régulières sont-elles importantes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles permettent de surveiller l'évolution et d'ajuster les traitements." } }, { "@type": "Question", "name": "Quels traitements existent pour les anomalies de glycosylation ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des thérapies de soutien et des interventions spécifiques selon les symptômes." } }, { "@type": "Question", "name": "Les enzymes de remplacement sont-elles efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être efficaces pour certaines formes de maladies liées à la glycosylation." } }, { "@type": "Question", "name": "La diététique joue-t-elle un rôle dans le traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des régimes spécifiques peuvent aider à gérer certains symptômes." } }, { "@type": "Question", "name": "Les médicaments immunosuppresseurs sont-ils utilisés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être prescrits pour traiter des complications immunitaires." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux disponibles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des essais cliniques sont en cours pour de nouvelles thérapies ciblées." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de la glycosylation ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles neurologiques, des infections et des problèmes de croissance." } }, { "@type": "Question", "name": "Les infections sont-elles fréquentes chez ces patients ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients peuvent être plus susceptibles aux infections en raison d'un système immunitaire affaibli." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer associés ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines anomalies de glycosylation peuvent augmenter le risque de cancers spécifiques." } }, { "@type": "Question", "name": "Les troubles cardiovasculaires sont-ils liés ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cardiovasculaires peuvent survenir chez certains patients." } }, { "@type": "Question", "name": "Les complications psychologiques sont-elles possibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications psychologiques comme l'anxiété peuvent être observées." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les anomalies de glycosylation ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux et certaines mutations génétiques sont des facteurs de risque." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle dans la glycosylation ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Certaines anomalies peuvent se manifester plus tôt dans l'enfance, mais d'autres plus tard." } }, { "@type": "Question", "name": "Les facteurs environnementaux influencent-ils la glycosylation ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs environnementaux peuvent interagir avec des prédispositions génétiques." } }, { "@type": "Question", "name": "Les maladies métaboliques augmentent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies métaboliques peuvent être associées à des anomalies de glycosylation." } }, { "@type": "Question", "name": "Le sexe a-t-il un impact sur la glycosylation ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines anomalies peuvent avoir des manifestations différentes selon le sexe." } } ] } ] }

Sources (10000 au total)

Estimating reference intervals from an IPD meta-analysis using quantile regression.

Reference intervals, which define an interval in which a specific proportion of measurements from a healthy population are expected to fall, are commonly used in medical practice. Synthesizing informa... With the availability of individual participant data (IPD), non-parametric methods can be used to estimate reference intervals without any distributional assumptions. Furthermore, patient-level covari... We compared several non-parametric bootstrap methods through simulation studies to account for within-study correlation. Under fixed effects model, we recommend keeping the studies fixed and only rand... We proposed to use the quantile regression in the IPD meta-analysis to estimate the reference interval. Based on the simulation results, we identify an optimal bootstrap strategy for estimating the un...

Hospitalization costs of road traffic injuries in Hunan, China: A quantile regression analysis.

Healthcare expenditure of road traffic injuries in China has not been adequately investigated so far. We aim to provide comprehensive information about the hospitalization costs of inpatients who suff... We extracted the data of all inpatients (n = 60535) with road traffic injuries during the year 2019 from Chinese National Health Statistics Network Reporting System database in Hunan, China. We calcul... The median hospitalization cost was $853.48, and the median length of hospital stay was 9 days. Vulnerable road users accounted for 84.9 % of all cases. Medicine cost is the first driver of hospitaliz... Road traffic injuries cause huge healthcare costs for victims, most of whom are vulnerable road users. The total cost of hospitalization is incurred mainly for medicine, consumables, diagnosis, medica...

Incidence and Prognostic Implications of Cardiac-Implantable Device-Associated Tricuspid Regurgitation: A Meta-Analysis and Meta-Regression Analysis.

New-onset or worsening tricuspid regurgitation (TR) is a well-established complication encountered after cardiac implantable electronic devices (CIEDs). However, there are limited and conflicting data...

Relationship between obsessive compulsive symptomatology and severity of psychotic symptoms in schizophrenia: Meta-analysis and meta-regression analysis.

Schizophrenia patients often show obsessive-compulsive symptoms (OCS) and obsessive-compulsive disorder (OCD) and their presence has been associated with poorer prognosis. However, the impact of OCS/O... A systematic review and meta-analysis (SRMA) of studies comparing the severity of psychotic symptoms among schizophrenia patients with and without OCS/OCD was performed. Standardized mean difference (... Sixty-seven studies involving 7740 patients were included. Patients with schizophrenia and OCS/OCD showed a slightly higher severity of positive (SMD = 0.17, p value = 0.0089) and global psychotic sym... Comorbid OCS/OCD in schizophrenia has, at most, a minor impact on psychotic severity. Variability in this effect was considerable and was poorly explained by the covariates analyzed....

Endoscopic third ventriculostomy for shunt malfunction in the pediatric population: a systematic review, meta-analysis, and meta-regression analysis.

Despite growing published evidence of the merits of endoscopic third ventriculostomy (ETV) instead of shunt revision at the time of shunt malfunction (secondary ETV), concerns about its efficacy and c... In accordance with the PRISMA guidelines, systematic searches of Medline, Embase, and Cochrane Central were undertaken from database inception to September 7, 2022. ETV success was defined as the lack... Sixteen studies reporting on 584 patients who underwent secondary ETV for shunt malfunction were included in the meta-analysis. The overall pooled mean (95% CI) age was 6.1 (3-9) years, and 57.0% of p... This meta-analysis demonstrates that secondary ETV after shunt malfunction in pediatric patients is a feasible option with acceptable success rates and low complication rates. Clinical trial registrat...

Out-of-pocket expenditures associated with double disease burden in Pakistan: a quantile regression analysis.

Pakistan is currently experiencing a double burden of disease. Families with members having both communicable and noncommunicable diseases are at a greater risk of impoverishment due to enormous out-o... The study extracted a sample of 6,775 households with at least one member experiencing both communicable and noncommunicable diseases from the Household Integrated Economic Survey 2018-19. The dataset... Overall, 28.5% of households had double disease in 2018-19. The households with uneducated heads, male heads, outpatient healthcare, patients availing public sector healthcare services, and rural and ... The coexistence of communicable and noncommunicable diseases is associated with excessive private healthcare costs in Pakistan. The results call for addressing the variations in financial costs associ...

Incidence and mortality of thyroid cancer in 50 countries: a joinpoint regression analysis of global trends.

To evaluate the incidence and mortality trend of thyroid cancer, and compare its global incidence trends among different countries by age group and sex.... Data on age-standardized incidence and mortality rate of thyroid cancer among 50 countries were collected from the Cancer Incidence in Five Continents Volume XI; the Surveillance, Epidemiology, and En... The age-standardized incidence of thyroid cancer was 3.1 and 10.1 cases per 100,000 persons in men and women, respectively. The incidence of thyroid cancer increased in most countries among individual... An increasing incidence of thyroid cancer was observed in younger subjects in a majority of countries, highlighting the need for more preventive strategies in this population and possible avoidance of...